Transport derived Ultrafines and the Brain Effects
The aim of the research is to study the effects of smallest traffic related ultrafine- or nanoparticles beyond the lung on brain health. Air pollutants have been shown to cause a vast amount of different adverse health effects. T...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
CGL2011-26574
IMPACTO DE LAS EMISIONES DE MATERIAL PARTICULADO ATMOSFERICO...
160K€
Cerrado
CTM2015-65303-P
EVALUACION DE LA EXPOSICION Y LOS EFECTOS SOBRE LA SALUD DE...
178K€
Cerrado
CGL2011-29621
MECANISMOS DE TOXICIDAD Y FACTORES DE RIESGO DEL MATERIAL PA...
103K€
Cerrado
ExploreFNP
Exploring the Molecular Properties of Atmospheric Freshly Nu...
1M€
Cerrado
CGL2015-66777-C2-1-R
PREDICCION DE EMISIONES Y EXPOSICION A PARTICULAS MICRO Y NA...
105K€
Cerrado
Duración del proyecto: 54 meses
Fecha Inicio: 2019-04-11
Fecha Fin: 2023-10-31
Líder del proyecto
ITASUOMEN YLIOPISTO
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
6M€
Descripción del proyecto
The aim of the research is to study the effects of smallest traffic related ultrafine- or nanoparticles beyond the lung on brain health. Air pollutants have been shown to cause a vast amount of different adverse health effects. These effects include impairment of many respiratory (e.g. asthma, COPD) and cardiovascular (ischemic heart disease, infarction, stroke) diseases. However, in recent years, the evidence showing effects beyond the lungs and circulatory system are becoming more evident. Neurological diseases, namely Alzheimer´s disease (AD) has shown to be associated with living near traffic. However, reason for this has remained unresolved until today. This consortium aims on revealing the mechanisms and exposures both behind cardiorespiratory diseases and beyond the current knowledge in neurological diseases. This consortium includes experts in areas of aerosol technology, emission research, engine and fuel research, human clinical studies, epidemiology, emission inventories, inhalation toxicology, neurotoxicology and disease mechanism studies. This enables research of resolving the effects of nanoparticles from different traffic modes for both air quality and concomitant toxic effect of these air pollutants. In this study, we will investigate adverse effects of air pollutants using cell cultures, animal exposures and volunteered human exposures as well as the material from epidemiological cohort study. These are going to be compared according to inflammatory, cytotoxic and genotoxic changes and furthermore beyond the current state of the art to neurotoxic and brain health effects. With this approach, we are aiming in to a comprehensive understanding of the adverse effects of nanoparticles from traffic. In current situation only particles above 23nm are measured in regulations, traditional toxicological methods are used in risk assessment and emission inventories and regulations are largely based on old technology engines. Our project will change this.